CLASS II Device recall · Reported 7 Aug 2019 · FDA Enforcement Report

Azurion lnterventional Fluoroscopic X-ray System recalled

Philips Medical Systems Nederlands is recalling Azurion lnterventional Fluoroscopic X-ray System, distributed nationwide in the US. The recall was initiated on 30 Nov 2018 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codessoftware version R1.2
Quantity recalled229

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1997-2019
FDA event ID
83366
Recalling firm
Philips Medical Systems Nederlands, Best, N/A
Classification
Class II
Status
Terminated
Recall initiated
30 Nov 2018
FDA classified
30 Jul 2019
Reported
7 Aug 2019
Type
FDA Mandated
Customers notified by
Letter
Reason category
Device Malfunction

Timeline

30 Nov 2018Recall initiated by company
30 Jul 2019Classified by FDA+242 days
7 Aug 2019Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Philips has discovered through customer complaints and internal testing an intermittent electronic product defect in accordance with 21 CFR 1003.2(b)(1). When performing Cine runs, the Azurion's automatic exposure control software may set technique factors that result in radiation emissions too low to obtain useful diagnostic images.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

Azurion lnterventional Fluoroscopic X-ray System, with software version 1.2

Where it was distributed

Nationwide

Nationwide

Questions about this recall

Why was it recalled?

Philips has discovered through customer complaints and internal testing an intermittent electronic product defect in accordance with 21 CFR 1003.2(b)(1). When performing Cine runs, the Azurion's automatic exposure control software may set technique factors that result in radiation emissions too low to obtain useful diagnostic images.

Which lots are affected?

software version R1.2

Where was it sold?

Nationwide

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Philips Medical Systems Nederlands

All 79

Other Imaging Equipment recalls

All 2,347